Sign in
Author
|
Conference
|
Journal
|
Organization
|
Year
|
DOI
Look for results that meet for the following criteria:
since
equal to
before
between
and
Search in all fields of study
Limit my searches in the following fields of study
Agriculture Science
Arts & Humanities
Biology
Chemistry
Computer Science
Economics & Business
Engineering
Environmental Sciences
Geosciences
Material Science
Mathematics
Medicine
Physics
Social Science
Multidisciplinary
Co-authors
(9)
Sophie Leboulleux
3
Claire Bournaud
3
Nadine Guilabert
3
S everine Gupta (S ´ everine Gupta)
3
Marcel Ricard
2
Journals
(1)
J NUCL MED
1
Keywords
(9)
Embed
Subscribe
Academic
Authors
Jerome Garsi
Jerome Garsi,Medicine
Edit
Jerome Garsi
Publications:
3
|
Citations:
11
Fields:
Medicine
View FAQ about top research areas and Fields of study
Collaborated with
9 co-authors
from 2008 to 2009
|
Cited by
18 authors
Cumulative
Annual
Sort by:
Publications
(3)
BibTeX
|
RIS
|
RefWorks
Download
The whole-body radiation delivered by 131 I remnant ablation can be significantly reduced by preparing patients with recombinant human thyrotropin rather than with thyroid hormone withdrawal
Leboulleux S
,
Guilabert N
,
Lavielle F
,
Garsi J
,
Bournaud C
,
Gupta S
Published in 2009.
131I Effective Half-Life and Dosimetry in Thyroid Cancer Patients
(
Citations: 6
)
H. Remy
,
I. Borget
,
S. Leboulleux
,
N. Guilabert
,
F. Lavielle
,
J. Garsi
,
C. Bournaud
,
S. Gupta
,
M. Schlumberger
,
M. Ricard
Journal:
Journal of Nuclear Medicine - J NUCL MED
, vol. 49, no. 9, pp. 1445-1450, 2008
131I Effective Half-Life and Dosimetry in Thyroid Cancer Patients
(
Citations: 5
)
Herve Remy
,
Isabelle Borget
,
Sophie Leboulleux
,
Nadine Guilabert
,
Jerome Garsi
,
Claire Bournaud
,
S ´ everine Gupta
,
Martin Schlumberger
,
Marcel Ricard
Sort by:
Citations
(11 times by 7 publications)
The absorbed dose to the blood is a better predictor of ablation success than the administered 131 I activity in thyroid cancer patients
(
Citations: 4
)
Frederik A. Verburg
,
Michael Lassmann
,
Uwe Mäder
,
Markus Luster
,
Christoph Reiners
,
Heribert Hänscheid
Journal:
European Journal of Nuclear Medicine and Molecular Imaging - EUR J NUCL MED MOL IMAGING
, vol. 38, no. 4, pp. 673-680, 2011
Radioiodine for remnant ablation and therapy of metastatic disease
Heribert Hänscheid
,
Markus Luster
,
Michael Lassmann
,
Frederik A. Verburg
,
Christoph Reiners
Journal:
Nature Reviews Endocrinology - NAT REV ENDOCRINOL
, vol. 7, no. 10, pp. 589-595, 2011
ALARA in rhTSH-stimulated post-surgical thyroid remnant ablation: what is the lowest reasonably achievable activity?
(
Citations: 3
)
Daniele Barbaro
,
Frederik A. Verburg
,
Markus Luster
,
Christoph Reiners
,
Domenico Rubello
Journal:
European Journal of Nuclear Medicine and Molecular Imaging - EUR J NUCL MED MOL IMAGING
, vol. 37, no. 7, pp. 1251-1254, 2010
Recombinant human thyroid-stimulating hormone as an alternative for thyroid hormone withdrawal in thyroid cancer management
Ming-Kai Chen
,
Indukala Doddamane
,
David W Cheng
Journal:
Current Opinion in Oncology - CURR OPIN ONCOL
, vol. 22, no. 1, pp. 6-10, 2010
Comment on: Recombinant human TSH in differentiated thyroid cancer: a nuclear medicine perspective
(
Citations: 1
)
Markus Luster
,
Martin Schlumberger
,
Furio Pacini
Journal:
European Journal of Nuclear Medicine and Molecular Imaging - EUR J NUCL MED MOL IMAGING
, vol. 36, no. 2, pp. 329-330, 2009
Comments